Tower Research Capital (TRC)’s Broadstone Acquisition Corp. BSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-602
Closed -$6K 6197
2021
Q1
$6K Sell
602
-195
-24% -$1.97K ﹤0.01% 4636
2020
Q4
$8K Buy
+797
New +$7.82K ﹤0.01% 4463

Other funds holding BSN

Tower Research Capital (TRC)'s BSN Position: Q2 2021 in Review

Tower Research Capital (TRC) sold out of Broadstone Acquisition Corp. (BSN) in Q2 2021, closing a stake of 602 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in BSN in Q4 2020 and held it in 2 quarters. The position peaked at $8K in Q4 2020. 63 funds tracked by Wall St. Rank hold BSN as of Q2 2021.

  • Tower Research Capital (TRC) reported no remaining Broadstone Acquisition Corp. position as of Q2 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 602 Broadstone Acquisition Corp. shares in Q2 2021, an estimated $6K.
  • Tower Research Capital (TRC) first reported a position in Broadstone Acquisition Corp. in Q4 2020 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Broadstone Acquisition Corp. position peaked at $8K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held Broadstone Acquisition Corp. as of Q2 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.